If you are:
Only When Necessary: INSUFF HUMAN DATA AVAIL; UNTREATED MATERNAL INFECTION MAY HAVE ADV FETAL EFFECTS
Precaution: CDC REC CONTINUING BREASTFEEDING DURING ANTIVIRAL TREATMENT OR PROPHYLAXIS
Giving oseltamivir PHOSPHATE to a child under 12:
management or monitoring precaution: Monitor for abnormal behavior. Possible risk of confusion and seizure. Nausea and vomiting more common age < 1 year.
management or monitoring precaution: Safety and efficacy not established age < 2 weeks. Risk of vomiting, diarrhea, behavioral changes.